UBS Group’s Exela Technologies 6.00% Series B Convertible Preferred Stock XELAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1 Hold
50
– – ﹤0.01% 11131
2026
Q2
$0 Buy
+50
New – ﹤0.01% 11424
2024
Q4
– Sell
-400
Closed -$640 – 10684
2024
Q3
$640 Sell
400
-230
-37% -$366 ﹤0.01% 8860
2024
Q2
$1.07K Sell
630
-206
-25% -$386 ﹤0.01% 8665
2024
Q1
$1.69K Buy
+836
New +$1.25K ﹤0.01% 8078
2023
Q3
– Sell
-4
Closed -$16 – 10116
2023
Q2
$16 Sell
4
-160
-98% -$340 ﹤0.01% 8710
2023
Q1
$489 Sell
164
-7,019
-98% -$16K ﹤0.01% 9013
2022
Q4
$21K Sell
7,183
-2,254
-24% -$8.35K ﹤0.01% 7595
2022
Q3
$46K Buy
9,437
+8,948
+1,830% +$52.7K ﹤0.01% 6438
2022
Q2
$3K Buy
+489
New +$3.33K ﹤0.01% 9394

Other funds holding XELAP

UBS Group's XELAP Position: Q3 2026 in Review

UBS Group held its Exela Technologies 6.00% Series B Convertible Preferred Stock (XELAP) position steady in Q3 2026 at 50 shares worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #11131.

UBS Group first reported a position in XELAP in Q2 2022 and has held it in 10 quarters since. The position peaked at $46K in Q3 2022. 5 funds tracked by Wall St. Rank hold XELAP as of Q3 2026.

  • UBS Group held 50 shares of Exela Technologies 6.00% Series B Convertible Preferred Stock worth $1 as of Q3 2026.
  • UBS Group left its Exela Technologies 6.00% Series B Convertible Preferred Stock share count unchanged in Q3 2026.
  • Exela Technologies 6.00% Series B Convertible Preferred Stock made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #11131 holding.
  • UBS Group first reported a position in Exela Technologies 6.00% Series B Convertible Preferred Stock in Q2 2022 and has held it in 10 quarters since.
  • UBS Group's Exela Technologies 6.00% Series B Convertible Preferred Stock position peaked at $46K in Q3 2022.
  • 5 funds tracked by Wall St. Rank held Exela Technologies 6.00% Series B Convertible Preferred Stock as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.